Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial

Four hundred myopic children randomly received atropine 0.02% (n = 138) or 0.01% (n = 142) in both eyes once-nightly or only wore single-vision spectacles (control group) (n = 120) for 2 years. Spherical equivalent refractive error (SER), axial length (AL), pupil diameter (PD), and amplitude of acco...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Can, Li, Xiujuan, Lyu, Yong, Wei, Li, Zhao, Bingxin, Yu, Shiao, Rong, Junbo, Bai, Yanhui, Fu, Aicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592985/
https://www.ncbi.nlm.nih.gov/pubmed/34782708
http://dx.doi.org/10.1038/s41598-021-01708-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592985/
https://www.ncbi.nlm.nih.gov/pubmed/34782708
http://dx.doi.org/10.1038/s41598-021-01708-2

Ejemplares similares